Ontogeny of dopamine agonist-induced sensitization: Role of NMDA receptors

Psychopharmacology

Volumn 129, Issue 2, 1997, Pages 153-160

  Duke, Marcus A ^a,b   O'Neal, Jason ^a   McDougall, Sanders A ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

amphetamine; dizocilpine (MK 801); NPA; sensitization

Indexed keywords

DEXAMPHETAMINE; DIZOCILPINE; DOPAMINE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROPYLNORAPOMORPHINE;

AGE; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; RAT; SENSITIZATION;

AMPHETAMINE; ANIMALS; ANIMALS, SUCKLING; APOMORPHINE; DIZOCILPINE MALEATE; DOPAMINE AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOTYPED BEHAVIOR;

EID: 0031037564     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050175     Document Type: Article

References (41)

1. Aizenstein ML, Segal DS, Kuczenski R (1990) Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization. Neuropsychopharmacology 3: 283-290
2. 3H]-dopamine from striatal slices. J Pharmacol Exp Ther 257: 262-270
3. Cador M, Bjijou Y, Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65: 385-395
4. De Montis MG, Devoto P, Meloni D, Gambarana C, Giorgi G, Tagliamonte A (1992) NMDA receptor inhibition prevents tolerance to cocaine. Pharmacol Biochem Behav 42: 179-182
5. Drew KL, Glick SD (1989) Environment-dependent sensitization to amphetamine-induced circling behavior. Pharmacol Biochem Behav 31: 705-708
6. Druhan JP, Jakob A, Stewart J (1993) The development of behavioral sensitization to apomorphine is blocked by MK-801. Eur J Pharmacol 243: 73-77
7. Fujiwara Y, Kazahaya Y, Nakashima M, Sato M, Otsuki S (1987) Behavioral sensitization in the rat: an ontogenic study. Psychopharmacology 91: 316-319
8. Kalivas PW, Alesdatter JE (1993) Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267: 486-495
9. Kalivas PW, Duffy P (1990) Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5: 48-58
10. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16: 223-244
11. Kamata K, Rebec GV (1984) Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area. Life Sci 34: 2419-2427
12. Karler R, Calder LD (1992) Excitatory amino acids and the actions of cocaine. Brain Res 582: 143-146
13. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45: 599-606
14. Karler R, Chaudhry IA, Calder LD, Turkanis SA (1990) Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res 537: 76-82
15. Kolta MG, Scalzo FM, Ali SF, Holson RR (1988) Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats. Psychopharmacology 100: 377-382
16. Leith NJ, Kuczenski R (1982) Two dissociable components of behavioral sensitization following repeated amphetamine administration. Psychopharmacology 76: 310-315
17. Mattingly BA, Gotsick JE (1989) Conditioning and experiential factors affecting the development of sensitization to apomorphine. Behav Neurosci 103: 1311-1317
18. McDougall SA, Duke MA, Bolanos CA, Crawford CA (1994) Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists. Psychopharmacology 116: 483-490
19. Nausieda PA, Weiner WJ, Kanapa DJ, Klawans HL (1978) Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism, Neurology 28: 1183-1188
20. Ohmori T, Abekawa T, Muraki A, Koyama T (1994) Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol Biochem Behav 48: 587-591
21. Pudiak CM, Bozarth MA (1993) L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci 53: 1517-1524
22. Rajachandran L, Goodwin GG, Spear LP (1991) Psychopharmacological effects of MK-801 in infant and preweanling rat pups. Pharmacol Biochem Behav 40: 291-295
23. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11: 157-198
24. Robinson TE, Becker JB, Presty SK (1982) Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res 571: 330-337
25. Robinson TE, Jurson PA, Bennett JA, Bentgen KM (1988) Persistent sensitization to dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462: 211-222
26. Scalzo FM, Burge LJ (1994) The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Neurotoxicology 15: 191-200
27. Segal DS, Kuczenski R (1987) Behavioral and neurochemical characteristics of stimulant-induced augmentation. Psychopharmacol Bull 23: 417-424
28. Segal DS, Kuczenski R, Florin SM (1995) Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? Behav Neurosci 109: 532-546
29. Smith RC, Strong JR, Hicks PB, Samorajski T (1979) Behavioral evidence for supersensitivity after chronic bromocriptine administration. Psychopharmacology 60: 241-246
30. Stewart J, Druhan JP (1993) Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology 110: 125-132
31. Stewart J, Vezina P (1989) Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 495: 401-406
32. Trujillo KA, Akil H (1995) Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend 38: 139-154
33. Weihmuller FB, O'Dell SJ, Cole BN, Marshall JF (1991) MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study. Brain Res 549: 230-235
34. Weiss F, Paulus MP, Lorang MT, Koob GF (1992) Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration. J Neurosci 12: 4372-4380
35. White FJ, Wang RY (1984) Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Res 309: 283-292
36. Wilcox RE, Riffee WH, Chen P, Hammett S, Smith RV (1980) Behavioral facilitation following chronic administration of N-n-propylnorapomorphine. Psychopharmacology 72: 113-115
37. Wolf ME, Jeziorski M (1993) Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613: 291-294
38. Wolf ME, Khansa MR (1991) Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562: 164-168
39. Wolf ME, White FJ, Hu X-T (1994a) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14: 1735-1745
40. Wolf ME, Xue C-J, White FJ, Dahlin SL (1994b) MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res 666: 223-231
41. Wolf ME, Dahlin SL, Hu X-T, Xue C-J, White K (1995) Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience 69: 417-439